Dr. Kerr is Chief Development Officer at Generation Bio. He previously served as global development team lead and vice president for neurology at Shire \where he was responsible for the development of the rare neuroscience programs. He also served as senior director of corporate strategy and portfolio management at Biogen, where he led the development effort for myotonic dystrophy and other neuromuscular diseases. Dr. Kerr was on the faculty of The Johns Hopkins School of Medicine as associate professor of neurology with joint appointments in the Department of Molecular Microbiology and Immunology and Cellular and Molecular Medicine, and ran a lab that investigated fundamental aspects of motor neuron/axon biology, provided direct patient care and ran clinical trials. He received his medical degree from Jefferson Medical College, as well as his doctorate in biochemistry and molecular biology. Dr. Kerr obtained his Master of Business Administration, with a specialization in entrepreneurship and finance, as well as his Bachelor of Science degree in molecular biology from Princeton University.